Femasys gains UK approval for women's health products
ATLANTA - Femasys Inc. (NASDAQ:FEMY), a biomedical company specializing in women's health, has announced the UK regulatory approval of three of its products: the FemaSeed Intratubal Insemination ...
Dysmenorrhea Treatment Market Expected To Achieve USD 10.1 Billion By 2032, Growing At 8.2% CAGR
Dysmenorrhea Treatment Market size is expected to be worth around USD 10.1 Bn by 2032 from USD 4.7 Bn in 2023, growing at a CAGR of 8.2% ...
Mamamia on MSN1d
All of the promises the government has made that will impact women.
Women are at the forefront this election season, with the Albanese government unveiling plans to spend $573 million on ...
What Do The Changes To IUD Access Mean For Australian Women?
Ahead of the government's response this week to a Senate inquiry into access to reproductive health care in Australia, the government has announced n ...